PORTO @ 
Archivio Istituzionale della Ricerca
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
EnglishHere a review concerning drugs used in Italy against Covid-19 and its effects on humans. The main source of information about trials is the Italian Government. Related links are given. From thse links, the names of trials and drugs involved have been obtained. Some information and references about drugs have been collected from other web sites. References to scholar papers and news are also given. Drugs mentioned are Tocilizumab, Sarilumab, Siltuximab, Canakinumab, Baricitinib, Methylprednisolone, Selinexor, Hydroxychloroquine, Enoxaparin sodium, Solnatide, Colchicine, Emapalumab, Anakinra, Remdesivir, Camostat, Nafamostat, Ivermectin.
Drugs used in Italy against Covid-19 / SPARAVIGNA, Amelia Carolina. - ELETTRONICO. - (2020).
| Titolo: | Drugs used in Italy against Covid-19 | |
| Autori: | ||
| Data di pubblicazione: | 2020 | |
| Citazione: | Drugs used in Italy against Covid-19 / SPARAVIGNA, Amelia Carolina. - ELETTRONICO. - (2020). | |
| Abstract: | Here a review concerning drugs used in Italy against Covid-19 and its effects on humans. The main source of information about trials is the Italian Government. Related links are given. From thse links, the names of trials and drugs involved have been obtained. Some information and references about drugs have been collected from other web sites. References to scholar papers and news are also given. Drugs mentioned are Tocilizumab, Sarilumab, Siltuximab, Canakinumab, Baricitinib, Methylprednisolone, Selinexor, Hydroxychloroquine, Enoxaparin sodium, Solnatide, Colchicine, Emapalumab, Anakinra, Remdesivir, Camostat, Nafamostat, Ivermectin. | |
| Handle: | http://hdl.handle.net/11583/2823007 | |
| Appare nelle tipologie: | 5.15 Pubblicazione su portale |
File in questo prodotto:
| File | Descrizione | Tipologia | Licenza | |
|---|---|---|---|---|
| drugs.pdf | 2a Post-print versione editoriale / Version of Record |  | Visibile a tuttiVisualizza/Apri |
http://hdl.handle.net/11583/2823007
Copyright © 2022